- Conditions
- Prostate CA, Androgen Deprivation Therapy
- Interventions
- Fezolinetant
- Drug
- Lead sponsor
- University of Vermont
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 83
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Menopause, Hot Flashes
- Interventions
- Shatavari (Asparagus racemosus) Extract, Placebo
- Dietary Supplement · Other
- Lead sponsor
- India Glycols Ltd
- Industry
- Eligibility
- 45 Years to 60 Years · Female only
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- New Port Richey, Florida
- Conditions
- Hot Flashes
- Interventions
- Estradiol transdermal one 90 μL spray, Estradiol transdermal spray, two 90 μL sprays, Estradiol transdermal three 90 μL sprays, Placebo transdermal two 90 μL sprays, Placebo transdermal three 90 μL sprays, Placebo transdermal one 90 μL spray
- Drug
- Lead sponsor
- Lumara Health, Inc.
- Industry
- Eligibility
- 35 Years and older · Female only
- Enrollment
- 454 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Oro Valley, Arizona + 37 more
- Conditions
- Hot Flashes
- Interventions
- Gabapentin Extended Release tablets, Gabapentin
- Drug
- Lead sponsor
- Depomed
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 8
- States / cities
- Burbank, California • DeLand, Florida • Port Orange, Florida + 5 more
- Conditions
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes, Healthy Volunteers
- Interventions
- Elinzanetant (BAY3427080)
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Vasomotor Symptoms
- Interventions
- Asimadoline
- Drug
- Lead sponsor
- Tioga Pharmaceuticals
- Industry
- Eligibility
- 40 Years to 62 Years · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Menopause, Menopause Related Conditions, Menopause Syndrome
- Interventions
- Hot water therapy, Warm water immersion
- Behavioral
- Lead sponsor
- University of Colorado, Colorado Springs
- Other
- Eligibility
- 40 Years to 80 Years · Female only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Colorado Springs, Colorado
- Conditions
- Menopause, Menopause Hot Flashes, Menopause Related Conditions
- Interventions
- Haelan 951
- Dietary Supplement
- Lead sponsor
- Spectrum Clinical Research, LLC
- Network
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Kansas City, Missouri
- Conditions
- Hot Flashes, Prostate Cancer
- Interventions
- oral soy protein/isoflavones powder, Venlafaxine, Placebo Powder, Placebo Pill
- Dietary Supplement · Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 21 Years and older · Male only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 20
- States / cities
- Newark, Delaware • Chicago, Illinois • Decatur, Illinois + 15 more
- Conditions
- Breast Cancer, Hot Flashes, Sexual Dysfunction, Fertility, Contraception
- Interventions
- Reproductive Health Survivorship Care Plan (SCPR), Control
- Other
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 182 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Menopause, Hot Flashes, Night Waking
- Interventions
- Elinzanetant (BAY3427080), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 199 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 10
- States / cities
- Mesa, Arizona • San Diego, California • Aventura, Florida + 6 more
- Conditions
- Hot Flashes
- Interventions
- Brisdelle (paroxetine mesylate), Sugar pill
- Drug
- Lead sponsor
- Noven Therapeutics
- Industry
- Eligibility
- 41 Years and older · Female only
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 10
- States / cities
- Lake Worth, Florida • Naples, Florida • Greensboro, North Carolina + 6 more
- Conditions
- Hot Flashes, Menopause, Vasomotor System; Labile
- Interventions
- Sympathoexcitatory stressors, Sodium Nitroprusside, Acetylcholine, Terbutaline, Norepinephrine
- Other · Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 40 Years to 60 Years · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Prostate Cancer Metastatic
- Interventions
- Veru-944, Placebo
- Drug
- Lead sponsor
- Veru Inc.
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 93 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 24
- States / cities
- Glendale, Arizona • Los Angeles, California • San Bernardino, California + 20 more
- Conditions
- Hot Flushes, Vasomotor Symptoms
- Interventions
- MF101 5 g/day, Placebo, MF101 10 g/day
- Drug
- Lead sponsor
- Bionovo
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 1,200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2011
- U.S. locations
- 50
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Berkeley, California + 44 more
- Conditions
- Postmenopausal Symptoms
- Interventions
- Brisdelle (paroxetine mesylate), Placebo capsules
- Drug
- Lead sponsor
- Noven Therapeutics
- Industry
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 74
- States / cities
- Mobile, Alabama • Chandler, Arizona • Glendale, Arizona + 63 more
- Conditions
- Prostate Cancer, Hot Flashes, Vasomotor Symptoms
- Interventions
- Embr Wave
- Device
- Lead sponsor
- Dana-Farber Cancer Institute
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Vasomotor Symptoms Associated With Menopause
- Interventions
- Black cohosh, Multibotanical preparation, Multibotanical preparation + dietary soy counseling, Conjugated equine estrogen +/- medroxyprogesterone acetate
- Drug
- Lead sponsor
- Kaiser Permanente
- Other
- Eligibility
- 45 Years to 55 Years · Female only
- Enrollment
- 351 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2001 – 2004
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Vasomotor Symptoms Associated With Menopause, Hot Flashes
- Interventions
- Elinzanetant (BAY3427080), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 628 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 36
- States / cities
- Mobile, Alabama • Mesa, Arizona • Garden Grove, California + 30 more
- Conditions
- Vasomotor Symptoms
- Interventions
- desvenlafaxine succinate (DVS) SR, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 2,186 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 102
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 86 more
- Conditions
- Hot Flashes, Hot Flushes, Vasomotor Symptoms
- Interventions
- Stellate Ganglion Block Injection with Bupivicaine, Saline injection
- Drug
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 40 Years to 70 Years · Female only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2023
- U.S. locations
- 2
- States / cities
- Chicago, Illinois
- Conditions
- Hot Flashes
- Interventions
- FP-101, Placebo Comparator
- Drug
- Lead sponsor
- Fervent Pharmaceuticals
- Industry
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 12
- States / cities
- Champaign, Illinois • Cary, North Carolina • Charlotte, North Carolina + 9 more
- Conditions
- Hot Flashes, Menopause, Vasomotor Disturbance
- Interventions
- Low-dose 17-ß-estradiol with progesterone taper, Venlafaxine XR, Placebo
- Drug
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Eligibility
- 40 Years to 62 Years · Female only
- Enrollment
- 339 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2013
- U.S. locations
- 4
- States / cities
- Boston, Massachusetts • Chestnut Hill, Massachusetts • Philadelphia, Pennsylvania + 1 more
- Conditions
- Prostate Cancer, Prostate Cancer (Adenocarcinoma), Prostate Cancer Metastatic Disease, Prostate Cancer Recurrent, Prostate Carcinoma, Prostate Neoplasm, Prostate Adenocarcinoma, Prostate Cancer With Bone Metastasis, Vasomotor Disturbance, Vasomotor Symptoms, Vasomotor Symptoms (VMS), Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Vasomotor Symptoms; Hot Flashes, Androgen Deprivation Therapy, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen-deprivation Therapy, Hot Flashes, Hot Flushes, Hot Flushes and/or Sweats
- Interventions
- fezolinetant - reference formulation, Placebo
- Drug
- Lead sponsor
- Shehzad Basaria, M.D.
- Other
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts